학술논문
1589MO Opposition to a patent covering tisagenlecleucel: Using intellectual property (IP) legislation to defend sustainable access to cancer therapies
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S962-S962
Subject
Language
ISSN
0923-7534